Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules is a medicinal preparation containing a fixed combination of Chlordiazepoxide hydrochloride (5 mg), a benzodiazepine, and Clidinium bromide (2.5 mg), an anticholinergic, as the active ingredients. Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules are indicated to control emotional and somatic factors in gastrointestinal disorders. It may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
[1] Please importantly note that only the relevant portion of the related is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
[1]. https://rulings.cbp.gov/ruling/N320635